Neurocrine Biosciences (NBIX)
94.47
+0.39 +0.41%
NASDAQ
May 24, 13:37
Delayed 2m
USD
View All Key Stats
NBIX Key Stats
| Income Statement | |
| Revenue (TTM) | 232.71M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.20 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -106.03M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 98.66% |
| Profit Margin (Quarterly) | -58.83% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 8.493B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 35.99 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 23.30 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -40.29M |
| Return on Equity (TTM) | Upgrade |
View All NBIX News
NBIX News
-
WireHeadlineTime (ET)
-
Yahoo05/22 07:00
-
Yahoo05/14 19:22
-
MT Newswires05/14 14:43
-
Globe Newswire05/14 08:25
-
PR Newswire05/09 16:01
-
Yahoo05/09 06:00
-
PR Newswire05/08 14:00
-
Yahoo05/03 10:15
-
PR Newswire05/02 16:14
-
Yahoo05/02 13:52
View All Events
NBIX Events
| Date | Type | Description |
|---|---|---|
| 08/03/2018 | Misc | Neurocrine Biosciences Inc Second Quarter Earnings Conference Call in 2018 |
| 08/03/2018 | Earnings | Neurocrine Biosciences Inc Second Quarter Earnings Results in 2018 |
| 04/30/2018 17:00 EDT | Misc | Neurocrine Biosciences Inc First Quarter Earnings Conference Call in 2018 |
| 04/30/2018 | Earnings | Neurocrine Biosciences Inc First Quarter Earnings Results in 2018 |
| 02/13/2018 17:00 EST | Misc | Neurocrine Biosciences Inc Fourth Quarter Earnings Conference Call in 2017 |
| 02/13/2018 | Earnings | Neurocrine Biosciences Inc Fourth Quarter Earnings Results in 2017 |
| 11/01/2017 17:00 EDT | Misc | Neurocrine Biosciences Inc Third Quarter Earnings Conference Call in 2017 |
| 11/01/2017 | Earnings | Neurocrine Biosciences Inc Third Quarter Earnings in 2017 Release |
| 08/03/2017 14:00 PDT | Misc | Neurocrine Biosciences Inc Second Quarter Earnings Conference Call in 2017 |
| 08/03/2017 | Earnings | Neurocrine Biosciences Inc Second Quarter Earnings in 2017 Release |
NBIX Fundamentals
Income Statement View Statement
NBIX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
NBIX One Page Reports
- One Page Report Download
NBIX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 94.47 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.neurocrine.com
- Investor Relations URL: http://phoenix.corporate-ir.net/phoenix.zhtml?c=68817&p=irol-news&nyo=0
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Aug. 03, 2018
- Last Earnings Release: Apr. 30, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Dec. 29, 1995
- Description: Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.
NBIX Excel Add-In Codes
- Name: =YCI("NBIX","name")
- Description: =YCI("NBIX","description")
- Sector: =YCI("NBIX","sector")
- Industry: =YCI("NBIX","industry")
- Est. Current Fiscal Year End: =YCI("NBIX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other NBIX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NBIX Tweets Stocktwits
Advertisement
